Temporal trends in cardiovascular mortality among patients with hematological malignancies: a 20-year perspective
Over the last 2 decades, the rate of cardiovascular mortality amongst patients with underlying hematological malignancy has decreased.
Authors
- Kamaraj Karunanithi (ORCID: https://orcid.org/0000-0002-4708-8092)
- Husam Mohamed Abdel-Qadir (ORCID: https://orcid.org/0000-0002-7105-7931)
- Mamas A. Mamas (ORCID: https://orcid.org/0000-0001-9241-8890)
- Ofer Kobo (ORCID: https://orcid.org/0000-0001-7418-498X)
- Gemina Doolub (ORCID: https://orcid.org/0000-0002-3089-2690)
- Dmitry Abramov (ORCID: https://orcid.org/0000-0003-0571-3109)
- Vijay Bang
- Purvi Parwani (ORCID: https://orcid.org/0000-0002-4707-992X)
- Avraham Raichman
Institutions
- University of Toronto (CA)
- Loma Linda University (US)
- Lilavati Hospital & Research Centre (IN)
- University Hospitals of North Midlands NHS Trust (GB)
- Montreal Heart Institute (CA)
- Soroka Medical Center (IL)
- Hillel Yaffe Medical Center (IL)
- Loma Linda University Health Care (US)
- Institute for Clinical Evaluative Sciences (CA)
- Keele University (GB)
Publication Details
- Journal
- Expert Review of Cardiovascular Therapy
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1080/14779072.2025.2463332
- Citations
- 1
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 1.39